Stock CLCS CELL SOURCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Cell Source, Inc.

Equities

CLCS

US15114L1044

Market Closed - OTC Markets
Other stock markets
 17:54:58 09/05/2024 BST 		5-day change 1st Jan Change
0.0008 USD +300.00% Intraday chart for Cell Source, Inc. 0.00% -99.83%
03-22 Cell Source, Inc. announced that it has received $4.76017 million in funding CI
2023 Cell Source, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CELL SOURCE, INC. Stock Cell Source, Inc.
 32.82K - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 23.4B -
ARGENX SE Stock argenx SE
 21.78B -
GENMAB A/S Stock Genmab A/S
 18.09B
  1. Stock Market
  2. Equities
  3. CLCS Stock
  4. Charts Cell Source, Inc.
  5. Sector Chart